Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 9.5620.4132.4710.29-

What is the latest Core EBITDA Growth ratio of SAKAR HEALTHCARE ?

The latest Core EBITDA Growth ratio of SAKAR HEALTHCARE is 9.56 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20249.56
Mar202320.41
Mar202232.47
Mar202110.29
Mar2020-

How is Core EBITDA Growth of SAKAR HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 9.56
-53.16
Mar2023 20.41
-37.14
Mar2022 32.47
215.55
Mar2021 10.29
0
Mar2020 0 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare Core EBITDA Growth ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹693.5 Cr -0% 13.2% -1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,549.0 Cr -2% -8.4% 14.3% Stock Analytics
DIVIS LABORATORIES ₹175,673.0 Cr -0.2% 7.5% 48% Stock Analytics
CIPLA ₹118,908.0 Cr -0.3% -2.6% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,106.0 Cr -1% -4.1% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,494.0 Cr 0.3% 8% 6.2% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-0%

13.2%

-1.9%

SENSEX

-0.4%

0.3%

8.7%


You may also like the below Video Courses